Gene · 657
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies. | Cancers (Basel) | 2021 | 34298740 | PubTator, text mining | PubMed |
| Molecular profiling of basal cell carcinomas in young patients. | BMC Med Genomics | 2021 | 34284772 | PubTator, text mining | PubMed |
| Incidental findings from cancer next generation sequencing panels. | NPJ Genom Med | 2021 | 34282142 | PubTator, text mining | PubMed |
| Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway. | Nat Commun | 2021 | 34282140 | PubTator, text mining | PubMed |
| Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human. | Stem Cell Res Ther | 2021 | 34266496 | PubTator, text mining | PubMed |
| Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients. | Front Immunol | 2021 | 34262555 | PubTator, text mining | PubMed |
| Differences in the Platelet mRNA Landscape Portend Racial Disparities in Platelet Function and Suggest Novel Therapeutic Targets. | Clin Pharmacol Ther | 2021 | 34255863 | PubTator, text mining | PubMed |
| Cell competition acts as a purifying selection to eliminate cells with mitochondrial defects during early mouse development. | Nat Metab | 2021 | 34253906 | PubTator, text mining | PubMed |
| High-throughput measurements of bone morphogenetic protein/bone morphogenetic protein receptor interactions using biolayer interferometry. | Biointerphases | 2021 | 34241280 | PubTator, text mining | PubMed |
| Recombinant human bone morphogenetic protein 2 and 7 inhibit the degeneration of intervertebral discs by blocking the Puma-dependent apoptotic signaling. | Int J Biol Sci | 2021 | 34239363 | PubTator, text mining | PubMed |
| The Role of BMP Signaling in Endothelial Heterogeneity. | Front Cell Dev Biol | 2021 | 34235147 | PubTator, text mining | PubMed |
| Fallopian tube cancer- challenging to diagnose but not as infrequent as originally thought. | J Community Hosp Intern Med Perspect | 2021 | 34234914 | PubTator, text mining | PubMed |
| Updates in chemoprevention research for hereditary gastrointestinal and polyposis syndromes. | Curr Treat Options Gastroenterol | 2021 | 34211259 | PubTator, text mining | PubMed |
| Identification of germline cancer predisposition variants during clinical ctDNA testing. | Sci Rep | 2021 | 34211039 | PubTator, text mining | PubMed |
| Bioactive Lipid O-cyclic phytosphingosine-1-phosphate Promotes Differentiation of Human Embryonic Stem Cells into Cardiomyocytes via ALK3/BMPR Signaling. | Int J Mol Sci | 2021 | 34209900 | PubTator, text mining | PubMed |
| Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders. | Biomedicines | 2021 | 34206903 | PubTator, text mining | PubMed |
| Inhibiting Endothelial Cell Function in Normal and Tumor Angiogenesis Using BMP Type I Receptor Macrocyclic Kinase Inhibitors. | Cancers (Basel) | 2021 | 34204675 | PubTator, text mining | PubMed |
| Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden. | Pharmaceutics | 2021 | 34203761 | PubTator, text mining | PubMed |
| Sinking Our Teeth in Getting Dental Stem Cells to Clinics for Bone Regeneration. | Int J Mol Sci | 2021 | 34203719 | PubTator, text mining | PubMed |
| The Role of BMP Signaling in Osteoclast Regulation. | J Dev Biol | 2021 | 34203252 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/657/papers?page=46